Healthcare
0+
Dedicated industry experts around the globe
0+
Healthcare engagements over the past decade
Rapidly evolving market dynamics, regulatory forces and consumer expectations are continually adding new layers of complexity to the healthcare industry. Our healthcare and life sciences consulting expertise is built on a detailed understanding of each player across the value chain, from doctors and patients to payers, drug developers and manufacturers.
Sector Expertise
Pharma
From R&D to supply chain and operations to every facet of commercialisation.
Medical Technology
Innovative devices and protocols, integrated platforms, and digitally-powered selling.
Healthcare Payers
We can help you improve share in flat growth markets, build and buy into new, high-growth markets.
Providers & Services
Cost pressures and the global impact of healthcare reform are just two of many challenges.
AI in Life Sciences
We partner with life science companies to unlock AI‘s full potential across the value chain, including accelerating drug development and optimizing patient outcomes.
Real Outcomes
See how we helped a global biopharma leader use AI to quantify biopharma's transition risk in clinical trials.
Explore Case StudyHow sm Help
AI is re-centering innovation, helping to improve patient outcomes, reduce costs, and transform the entire healthcare ecosystem.
View ServicesClient Results
A Pharma Company's Finance Function Gets a Shot in the Arm
A financial transformation is powered by a strategic mid-state vision and a bridge approach.
Kayana Ignites AI-Driven Innovation by Unifying Its Data Ecosystem
Kayana harnessed its multi-sectoral scale with a comprehensive AI-driven transformation.
Global Healthcare Private Equity Report 2026
Record highs, renewed momentum, ready for more.
Featured Team Members
Joshua Weisbrod
Partner, New York
Vikram Kapur
Partner, Singapore
Lucy d'Arville
Partner, Sydney
Loïc Plantevin
Partner, Paris
Mayuri Shah
Partner, Mumbai
Insights
PRIVATE EQUITY
Big Deals Rule: Healthcare Private Equity Midyear Update
North American deals rebounded, large-scale assets and IT investments drew significant interest.
MEDICAL TECHNOLOGY
Enterprise Shared Services in Medtech: The Only Wrong Move Is Standing Still
As companies wrestle with margin pressure, acquisition debt, and spin-off opportunities.
PHARMA
Managing the Transition to a Multipolar Pharma Market
Biopharma leaders must reckon with the unbundling of the historical "one world, one molecule" model.
HEALTHCARE & LIFE SCIENCES
The Human Imperative: Scaling AI Across Life Sciences
Realizing meaningful, measurable value from AI depends on redesigning work, not just deploying technology.
How We Can Help
Performance Improvement
Read More→Go-to-Market Strategy
Read More→M&A
Read More→Agile Enterprise
Read More→Ready to Transform Your AI Strategy?
Let's discuss how our services can address your specific challenges and accelerate your AI journey.